Iridex Introduces New MicroPulse Device


■ Iridex Corporation, a provider of ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced the introduction of the second generation of the MicroPulse P3 Device, which has been redesigned to deliver greater stability, visualization, coupling, and fit.

“The revised MicroPulse P3 Device is intuitive and easy to use. The design delivers energy in a much more consistent fashion and allows for very stable contact on the sclera,” said Brian A. Francis, MD, associate professor of ophthalmology at the Doheny Eye Institute, Keck School of Medicine, University of Southern California. “This device offers myself and my patients a treatment paradigm that can be introduced prior to, in conjunction with, and following all other glaucoma treatment options, making it a very versatile tool in my practice.”